Dirk Walther

Director of Proteomics at Kymera Therapeutics

Greater Boston

About

Research scientist in industry with expert knowledge in mass spectrometry-based proteomics.

Experience

  • Kymera Therapeutics (Full-time · 5 yrs 7 mos)
    • Director of Proteomics
      Feb 2026 - Present · 5 mos

    • Associate Director
      Jul 2023 - Feb 2026 · 2 yrs 8 mos

    • Principal Scientist
      Dec 2020 - Jun 2023 · 2 yrs 7 mos

  • Biogen (6 yrs 3 mos)
    • Scientist II, Chemical Biology and Proteomics
      Jun 2018 - Dec 2020 · 2 yrs 7 mos

      Perform target validation using label-free and TMT-based proteomics workflows. Elucidate the mechanism of action drug candidates using data-dependent and targeted PTM analysis, including phosphorylation and ubiquitinantion.

    • Scientist I, Mechanisms and Pathways
      Oct 2014 - Dec 2020 · 6 yrs 3 mos

      Mass Spectrometry-based Proteomics

  • Visiting Scientist at Pontificia Universidad Católica de Chile
    May 2014 - Sep 2014 · 5 mos

    Analysis of spinal cord regeneration model using mass spectrometry based proteomics and RNA-Seq.

  • Max Planck Institute for Biochemistry (5 yrs 9 mos)
    • Postdoctoral Fellow
      Oct 2012 - Apr 2014 · 1 yr 7 mos

      Used SILAC-based quantitative proteomics to study changes in protein expression and protein aggregation during aging in nematodes. Performed IP-MS and protein correlation profiling (PCP) experiment to discover novel subunits of mitochondrial protein complexes.

    • PhD Student
      Aug 2008 - Oct 2012 · 4 yrs 3 mos

      PhD thesis on aging related proteome changes and protein aggregation in mice and nematodes

  • Diploma Student at University of Tübingen and Utrecht University
    Jun 2007 - Jul 2008 · 1 yr 2 mos

    Research on conserseved beta-barrel protein sorting in eukaryotes and bacteria